We are live on ! Find out more
OFM

Omega Fund Management Portfolio holdings

AUM $163M
1-Year Est. Return 107.06%
This Fund
S&P 500
This Quarter Est. Return
-21.29%
1 Year Est. Return
+107.06%
3 Year Est. Return
+111.75%
5 Year Est. Return
+84.24%
10 Year Est. Return
+495.59%
AUM
$169M
AUM Growth
+$15.3M
Cap. Flow
+$78.3M
Cap. Flow %
46.19%
Top 10 Hldgs %
97.9%
Holding
14
New
2
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
KMTS
Kestra Medical Technologies
KMTS
+$41.3M
2
BBNX
Beta Bionics
BBNX
+$37.1M

Top Sells

Rank Stock Value
1
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$57.8K

Sector Composition

Rank Sector Weight
1 Healthcare 99.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMTS
1
Kestra Medical Technologies
KMTS
$1.23B
$44.8M 26.41%
+1,795,893
New +$41.3M
BCAX
2
Bicara Therapeutics
BCAX
$1.78B
$28.7M 16.95%
2,204,650
– –
BBNX
3
Beta Bionics
BBNX
$706M
$24.3M 14.36%
+1,988,287
New +$37.1M
NUVB icon
4
Nuvation Bio
NUVB
$2.24B
$23M 13.58%
13,072,340
– –
REPL icon
5
Replimune Group
REPL
$814M
$19.3M 11.36%
1,975,203
– –
UPB
6
Upstream Bio Inc
UPB
$349M
$12.5M 7.35%
2,036,293
– –
LXEO icon
7
Lexeo Therapeutics
LXEO
$366M
$4.11M 2.43%
1,184,636
– –
ALMS
8
Alumis Inc
ALMS
$3.57B
$4.01M 2.37%
653,223
– –
IMA
9
ImageneBio Inc
IMA
$63.1M
$2.88M 1.7%
187,427
– –
ENGN icon
10
enGene Therapeutics
ENGN
$122M
$2.36M 1.39%
526,357
– –
IMUX icon
11
Immunic
IMUX
$182M
$1.95M 1.15%
178,816
– –
SANA icon
12
Sana Biotechnology
SANA
$885M
$1.42M 0.84%
843,750
– –
ENGNW icon
13
enGene Therapeutics Warrants
ENGNW
$3.75M
$193K 0.11%
321,502
– –
SYRS
14
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-251,270
Closed -$57.8K

Similar funds

HCCM
Hudson Canyon Capital Management New York $163M AUM 33.71% 1-Year Est. Return
PBO
Peoples Bank (Ohio) Marietta, Ohio $163M AUM 18.72% 1-Year Est. Return
PCR
Potrero Capital Research San Francisco, California $163M AUM 79.07% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
IVGAI
Index Venture Growth Associates IV St. Helier, Jersey $163M AUM 54.88% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
TCGDR
TB Capital Gestao de Recursos Rio De Janeiro $163M AUM 20.86% 1-Year Est. Return
IPWA
International Private Wealth Advisors San Diego, California $163M AUM 16.99% 1-Year Est. Return

Omega Fund Management's Q1 2025 Portfolio in Review

As of Q1 2025, Omega Fund Management held 14 positions worth $169M, up 9.9% from $154M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Omega Fund Management deployed $78.3M of net new capital in Q1 2025, opening 2 new positions. Its largest new stake was Kestra Medical Technologies: 1,795,893 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

On the sell side, the most notable exit was Syros Pharmaceuticals, Inc. Common Stock, an estimated $57.8K sold.

  • Omega Fund Management's largest Q1 2025 buy was Kestra Medical Technologies: 1,795,893 shares worth $44.8M.
  • Omega Fund Management fully exited Syros Pharmaceuticals, Inc. Common Stock in Q1 2025, selling an estimated $57.8K.
  • Omega Fund Management's ten largest holdings make up 98% of its $169M portfolio in Q1 2025.
  • Omega Fund Management opened 2 new positions and closed 1 in Q1 2025.
  • Omega Fund Management's portfolio value rose 9.9% quarter-over-quarter to $169M.

Based on Omega Fund Management's 13F filing for Q1 2025, filed 15 May 2025.